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In response to the comment on the feasibility of right
atrial bypass grafting in patients with dialysis access–asso-
ciated subclavian obstructions, several points should be
made.
First, the task of securing an adequate dialysis access is
becoming increasingly difficult with the aging of the dial-
ysis population. We agree that therapy for central venous
obstruction in general has been less than optimal, with low
patency rates after angioplasty and stent deployment. The
procedure described should not be considered the first
choice for securing an adequate access but may be used
when other measures fail or are not feasible.
Second, we believe that the nature and extent of
venous damage, and treatment expectations, in effort-
induced thrombosis differ from those of subclavian
obstruction associated with dialysis access. In effort-
induced thrombosis, the acute onset of symptoms, the
absence of previous vein instrumentation, and the local-
ized nature of the stenosis at the costoclavicular hiatus
account for the favorable results of surgery and interven-
tional procedures. In dialysis access–associated obstruc-
tion, the chronic nature of the venous damage from
repeated trauma and the resultant extension thrombosis
make repair quite challenging. Subsequent hypertension
on creation of a distal arteriovenous graft also contributes
to the venous damage. An isolated venous lesion is rarely
seen. More typically, several areas of narrowing are found.
In many instances, the axillary and subclavian veins were
explored and dissected proximally, only to have a diffusely
diseased vessel found. As pointed out by Gradman et al,1
the nature and distribution of intraluminal obstruction
after venotomy is surprisingly varied and rarely appreciat-
ed on preoperative contrast venogram or even on direct
external superior vena cava (SVC) examination before
venotomy. Most reports that describe the use of jugu-
lar/subclavian bypass grafting or turndown techniques
involve patients with acute effort-induced subclavian
thrombosis.
Third, although jugular vein transposition (introduced
in 1966 by White and Smith2 and again by Jacobson and
Haimov3 in 1977) represents a relatively safe method of
relieving obstruction in selected cases, this technique sac-
rifices the internal jugular vein (IJV), thus precluding its
use for temporary access, hemodynamic monitoring, or
even outflow for arteriovenous fistulas. Jugular vein trans-
position is not suitable in cases of stenosis of the subcla-
vian/jugular junction, innominate vein, and SVC, and is
contraindicated if the patient has occlusion of the con-
tralateral IJV. The procedure carries the risk of injury to
the phrenic nerve, thoracic duct, and structures at the
skull base. Finally, unless the clavicle is resected to allow
complete mobilization of the IJV down to the innominate
vein, the IJV kinks and may be functionally obstructed at
the point where it is turned back to reach the SVC. These
considerations compromise the overall use of the proce-
dure. Similarly, in the series of five cases of axillary-IJV
bypass grafts cited by Currier et al,4 three grafts clotted in
the first 3 months and only two remained patent after 1
year. All our patients had previously undergone temporary
bilateral subclavian and internal jugular vein dialysis
catheter placement, which precluded the use of the jugu-
lar approach in the majority of cases. Moreover, the ultra-
sound scan documentation of jugular vein patency does
not guarantee the suitability of the vein as an outflow
channel.
Fourth, in the patient who underwent brachial artery-
to-right atrial bypass grafting, the procedure was started as
a thrombectomy of an upper arm arteriovenous graft
(AVG). However, on exploration, extensive thrombosis of
the cephalic, axillary, and proximal subclavian veins was
discovered, so the venous limb of the AVG was extended
with a tapered expanded polytetrafluoroethylene graft to
the right atrium. A similar technique of subclavian artery-
to-right atrium bridge graft was reported by Mickley5 to
bypass an SVC occlusion. An externally reinforced,
tapered polytetrafluoroethylene graft (in our case, 8 to 10
mm) is designed to reduce shunt volume and the risk of
congestive heart failure.
Fifth, the causes of death of the patients were discon-
tinuation of dialysis on thrombosis of the AVG (patient 1)
and tuberculosis quadriplegia of the cervical spine (patient
2), both of which were not related to the procedure. Of
interest, the majority of patients (six of nine) in this series
were black. This observation was also made in a previous
report (Barrett et al6), which suggested that the predispo-
sition of black patients to keloid formation could affect the
complication rate.
Finally, patient selection is of paramount importance
because patency of the bypass graft unfortunately does not
guarantee long-term access function. In this era of limit-
ed-access surgery, this technique can be modified by use of
a limited right anterolateral thoracotomy for exposure of
the right atrium.
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